UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
udca (178) 178
science & technology (153) 153
life sciences & biomedicine (148) 148
ursodeoxycholic acid (111) 111
humans (108) 108
male (71) 71
gastroenterology & hepatology (64) 64
female (55) 55
animals (51) 51
biological and medical sciences (49) 49
ursodeoxycholic acid - therapeutic use (49) 49
ursodeoxycholic acid - pharmacology (46) 46
bile acids (45) 45
medical sciences (44) 44
middle aged (37) 37
udca, ursodeoxycholic acid (37) 37
ursodiol (34) 34
gastroenterology and hepatology (29) 29
adult (28) 28
liver (28) 28
primary biliary cirrhosis (28) 28
pharmacology & pharmacy (26) 26
pharmacology. drug treatments (26) 26
cholestasis (25) 25
abridged index medicus (22) 22
cholagogues and choleretics - therapeutic use (22) 22
treatment outcome (22) 22
apoptosis (21) 21
digestive system (21) 21
gastroenterology. liver. pancreas. abdomen (21) 21
rats (21) 21
biochemistry & molecular biology (20) 20
cdca (19) 19
liver. biliary tract. portal circulation. exocrine pancreas (19) 19
bile acids and salts - metabolism (18) 18
chenodeoxycholic acid (18) 18
hepatology (18) 18
mice (18) 18
analysis (17) 17
deoxycholic acid (17) 17
liver cirrhosis, biliary - drug therapy (17) 17
pbc (17) 17
liver - metabolism (16) 16
other diseases. semiology (16) 16
review (16) 16
time factors (16) 16
ursodeoxycholic acid - administration & dosage (16) 16
aged (15) 15
ウルソデオキシコール酸 (15) 15
bile (14) 14
ca, cholic acid (14) 14
dca, deoxycholic acid (14) 14
endocrinology & metabolism (14) 14
fxr, farnesoid x receptor (14) 14
liver - pathology (14) 14
care and treatment (13) 13
general & internal medicine (13) 13
medicine, general & internal (13) 13
cdca, chenodeoxycholic acid (12) 12
liver diseases (12) 12
primary sclerosing cholangitis (12) 12
risk factors (12) 12
acids (11) 11
apoptosis - drug effects (11) 11
cholagogues and choleretics - pharmacology (11) 11
deoxycholic acid - analogs & derivatives (11) 11
gastroenterology (11) 11
inflammation (11) 11
ursodeoxycholic acid - analogs & derivatives (11) 11
bile acid (10) 10
cells, cultured (10) 10
cholangitis (10) 10
cholesterol - metabolism (10) 10
fxr (10) 10
medicine, research & experimental (10) 10
oncology (10) 10
rats, sprague-dawley (10) 10
research & experimental medicine (10) 10
retrospective studies (10) 10
オキシ (10) 10
コール (10) 10
コール酸 (10) 10
シコー (10) 10
シコー技研 (10) 10
デオキシコール酸 (10) 10
cell biology (9) 9
dose-response relationship, drug (9) 9
lca, lithocholic acid (9) 9
medicine & public health (9) 9
original (9) 9
original article (9) 9
primary biliary cholangitis (9) 9
disease models, animal (8) 8
drug therapy, combination (8) 8
icp, intrahepatic cholestasis of pregnancy (8) 8
liver - drug effects (8) 8
liver cirrhosis (8) 8
liver cirrhosis, biliary - blood (8) 8
medical research (8) 8
medicine (8) 8
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (269) 269
Japanese (26) 26
Chinese (7) 7
Korean (7) 7
Russian (6) 6
German (4) 4
French (2) 2
Italian (2) 2
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of hepatology, ISSN 0168-8278, 2015, Volume 62, Issue 6, pp. 1398 - 1404
Gastroenterology and Hepatology | 3-hydroxy-3-methylglutaryl-CoA reductase | Stearoyl-CoA desaturase | Non-alcoholic fatty liver disease | Lipogenesis | FGF19 | 3-hydroxy-3-methylglutaryl- CoA reductase | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Ursodeoxycholic Acid - administration & dosage | Oleic Acid - metabolism | Bile Acids and Salts - biosynthesis | Humans | Liver - metabolism | Bile Acids and Salts - metabolism | Non-alcoholic Fatty Liver Disease - metabolism | Intra-Abdominal Fat - metabolism | Obesity, Morbid - drug therapy | Non-alcoholic Fatty Liver Disease - drug therapy | Ursodeoxycholic Acid - pharmacology | Stearoyl-CoA Desaturase - biosynthesis | Liver - drug effects | Receptors, Cytoplasmic and Nuclear - antagonists & inhibitors | Lipid Metabolism - drug effects | Intra-Abdominal Fat - drug effects | Obesity, Morbid - metabolism | Physiological aspects | Obesity | Ursodiol | Deoxycholic acid | Index Medicus | BAs, bile acids | nCEH, neutral cholesterol ester hydrolase | ApoB, apolipoprotein B | LDLR, low density lipoprotein receptor | FGF19, fibroblast growth factor 19 | VLDL, very low density lipoproteins | ABC, ATP-binding cassette | TGs, triglycerides | NAFLD, non-alcoholic fatty liver disease | OA, oleic acid | C4, 7α-hydroxy-4-cholesten-3-one | SHP, small heterodimer partner | SREBP1c, sterol regulatory element-binding protein-1c | CA, cholic acid | PA, palmitic acid | FATP1, fatty acid transport protein 1 | UDCA, ursodeoxycholic acid | FAs, fatty acides | HMGCR, 3-hydroxy-3-methylglutaryl-CoA reductase | vWAT, visceral white adipose tissue | SCD, stearoyl-Coa desaturase | CYP7A1, cholesterol 7α-hydroxylase | NASH, non-alcoholic steatohepatitis | FXR, farnesoid X receptor | CDCA, chenodeoxycholic acid | MA, myristic acid | FASN, fatty acid synthase | MTTP, microsomal triglyceride transfer protein | SA, stearic acid | NONALCOHOLIC | FATTY LIVER-DISEASE | NUCLEAR RECEPTOR | CHOLESTEROL-METABOLISM | TRANSPORT | Endokrinologi och diabetes | FEEDBACK-REGULATION | STEATOHEPATITIS | PLACEBO-CONTROLLED TRIAL | COA DESATURASE | EXPRESSION | Endocrinology and Diabetes | ADIPOSE-TISSUE | Medicin och hälsovetenskap
Journal Article
Journal of hepatology, ISSN 0168-8278, 2014, Volume 62, Issue 4, pp. 871 - 878
Gastroenterology and Hepatology | Schistosoma mansoni infection | Bile acids | Liver fibrosis | Anti-inflammatory/anti-fibrotic therapy | Hepatic granulomas | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Immunohistochemistry | Inflammation - pathology | Liver Cirrhosis - immunology | Cholagogues and Choleretics - pharmacology | Ursodeoxycholic Acid - analogs & derivatives | Schistosomiasis mansoni - immunology | Inflammation - drug therapy | T-Lymphocytes - drug effects | Disease Models, Animal | Schistosomiasis mansoni - physiopathology | Liver Cirrhosis - drug therapy | Liver Cirrhosis - etiology | Cholagogues and Choleretics - metabolism | Schistosomiasis mansoni - complications | Treatment Outcome | Inflammation - immunology | Granuloma - pathology | Ursodeoxycholic Acid - pharmacology | Animals | Lymphocyte Activation - drug effects | Liver Cirrhosis - pathology | Granuloma - drug therapy | Granuloma - immunology | T-Lymphocytes - immunology | Mice | Liver Cirrhosis - physiopathology | Schistosomiasis mansoni - pathology | Ursodeoxycholic Acid - metabolism | Drug Monitoring | Ursodiol | Liver diseases | Index Medicus | ALT, alanine aminotransferase | HP, hydroxyproline | Mdr2, canalicular phospholipid export pump | BMDC, bone marrow derived dendritic cells | BMDM, bone marrow derived macrophages | M-CSF, macrophage colony-stimulating factor | multidrug resistance protein 2 | norUDCA, 24-nor-ursodeoxycholic acid | anti-fibrotic therapy | Abcb4 | B. glabrata, Biomphalaria glabrata | UDCA, ursodeoxycholic acid | S. mansoni, Schistosoma mansoni | Anti-inflammatory | AP, alkaline phosphatase
Journal Article
Journal Article
Journal of hepatology, ISSN 0168-8278, 2015, Volume 63, Issue 4, pp. 952 - 961
Journal Article